Navigation Links
KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain
Date:5/24/2011

NORTH LIBERTY, Iowa, May 24, 2011 /PRNewswire/ -- KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of its most advanced opioid-based drug candidate, KP201, a novel hydrocodone prodrug for treating pain.  KP201 is a new chemical entity (NCE) composed of hydrocodone chemically bound to a ligand.

The data confirmed that KP201 is cleaved in man as predicted, releasing the active pharmaceutical compound hydrocodone into the bloodstream at amounts equivalent to the reference listed drug (RLD), Norco®.  Importantly, intact KP201 could not be detected in systemic circulation, indicating that minimal additional studies are warranted to determine the impact of KP201 exposure in the body.

"Our findings from this first clinical trial of KP201 are as good as we could have hoped," stated Sven Guenther, Ph.D., Vice President of Research at KemPharm. "The human pharmacokinetic profile of KP201 indicates that the prodrug releases hydrocodone efficiently and is bioequivalent to the comparator drug, supporting a 505(b)(2) regulatory pathway for KP201 in combination with acetaminophen. KP201 has unique physiochemical and pharmacological attributes that deliver additional patient benefits, including reduced potential for abuse as well as reduction or elimination of opioid-induced constipation."

The Phase 1 study was a single dose, three-treatment, three-period, six-sequence, cross-over PK study in which twenty-four healthy volunteers received oral doses of 5 mg KP201, 10 mg KP201, or 10/325 mg tablet of hydrocodone bitartrate and acetaminophen (Norco®, RLD).  The objectives of the study included evaluation of the serum concentrations of hydrocodone, certain metabolites, and intact KP201, as well as safety and tolerability.

"We believe KP201 has the potential to assume sizeable market share, given the opportunity for extended market exclusivity in acute and chronic pain, as well as the potential to mi
'/>"/>

SOURCE KemPharm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
2. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
3. KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... Bionik Laboratories, Inc., a Toronto ... accredited investors of units consisting of its common stock ... million. Shares of the Company,s common stock will continue ... symbol "DWTPD" until FINRA,s approval of the ticker "BNKL." ...
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
(Date:2/26/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... year 2014 financial results after the market closes on ... the Company will host a conference call with the investment ... Thursday, March 5, 2015 to discuss the results of ... may access the live conference call via telephone by dialing ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... 2011 SurgiCount Medical, Inc., the wholly-owned operating subsidiary ... today announced that it has signed an agreement, effective ... in one of the largest hospital operators in the ... a minimum number of hospitals, SurgiCount and the operator ...
... HeartWare International, Inc. (NASDAQ: HTWR ; ASX: ... support technologies that are revolutionizing the treatment of advanced ... HeartWare® Ventricular Assist System will be presented on Sunday, ... in Lisbon, Portugal. A presentation by Mark ...
Cached Medicine Technology:SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System 2SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System 3HeartWare Announces Presentation of Clinical Data at the 25th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Lisbon 2
(Date:2/28/2015)... 28, 2015 Pioneer Millworks reclaimed USA ... Architecture & Construction Materials Show, an annual, premier sustainable ... 1,000 suppliers and top manufacturers of the latest building ... products sourced and manufactured by Pioneer Millworks from ... in Japan at restaurants, hotels, retailers, and corporate offices. ...
(Date:2/28/2015)... A case management conference ( http://www.testosteronelawsuithub.com/ ... been filed by law firms including Bernstein Liebhard LLP ... the Firm notes. , According to a Calendar ... federal litigation will meet on March 13, 2015 at ... treatments designed to raise levels of the male hormone. ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... announce that they have officially relaunched their website. The ... user-friendly, but it contains a new section about their ... to read the full biographies of each Friedman Dental ... of the website was designed to provide our patients ...
(Date:2/28/2015)... 2015 “ Powermod ” was featured on ... a look at the latest and coolest technology products and ... NewsWatch and a technology expert, conducted the review and shared ... solutions. , Getting stuck with a low battery and no ... that people face on a daily basis. Even when a ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand in personal ... Nevada for the annual ASD Market Week tradeshow. , ... tradeshows and My Shiney Hiney will be one of the ... can be found at booth number C1663. , My Shiney ... hygiene brush and cleansing system exclusively created to clean and ...
Breaking Medicine News(10 mins):Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2
... Society, the leading professional and scientific organization dedicated to the ... Francesca M. Dea, CAE, to serve as the Society,s Executive ... with an accomplished record in nonprofit and small business management, ... Robert Kushner, MD, President of The Obesity Society, "We,re excited ...
... , MONDAY, July 6 (HealthDay News) -- A U.S. ... breast cancer cells survive in the bone marrow of patients ... issue of the journal Cancer Cell , could lead ... the researchers. , "We sought to identify signaling pathways that ...
... and Johns Hopkins University School of Medicine have collaborated ... of autism. Their new study, published in the journal ... children with autism and typically developing children learned to ... with autism appear to learn new actions differently than ...
... July 6, 2009 -- In a study to determine ... decision to treat nonmetastatic breast cancer, researchers at Columbia ... between oncologist characteristics and the receipt of chemotherapy in ... were more likely to receive chemotherapy if treated by ...
... of Arizona has announced that AM 1230 KOY will begin ... SCAN Health Plan to regularly share its health-related messages with ... , SCAN also will serve as a co-sponsor to KOY ... This initiative is part of the nonprofit health plan,s ongoing ...
... National Science Foundation (NSF) has awarded a four-year, ... Science Laboratory (NDSSL) at the Virginia Bioinformatics Institute ... petascale computing environments that model billions of individuals ... The anticipated arrival of high-performance computers that ...
Cached Medicine News:Health News:The Obesity Society Selects Executive Vice President 2Health News:Research Reveals Clues to Breast Cancer's Spread 2Health News:New study pinpoints difference in the way children with autism learn new behaviors 2Health News:New study pinpoints difference in the way children with autism learn new behaviors 3Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 2Health News:Elderly breast cancer patients receive chemotherapy if treated in private practices 3Health News:Arizona's AM 1230 KOY to be Broadcast from SCAN Health Plan Studios 2Health News:Virginia Bioinformatics Institute to develop petascale computer modeling capabilities 2Health News:Virginia Bioinformatics Institute to develop petascale computer modeling capabilities 3Health News:Virginia Bioinformatics Institute to develop petascale computer modeling capabilities 4
... will be the world wide sole distributor ... different from conventional drug eluting stents, the ... drug eluting stent designed to provide advanced ... allow release profiles to be tailored to ...
... background in high performance portable ultrasound ... field of echocardiography. Echocardiography (ultrasound) ... frame rates, and sensitive Doppler performance. ... based upon Terason's proprietary Teratech Architecture, ...
... myocardial infarction is suspected, every ... rapid assay allows rapid determination ... T from a single whole ... is available within minutes - ...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva....
Medicine Products: